Category:
Prophylactic Biological Products
CAS NO:
NA
Standard:
In-house Standards,
Glucosamine composite tablets are pharmaceutical formulations combining glucosamine salts with excipients for joint health support. Core manufacturing involves granulation and compression of glucosamine sulfate or hydrochloride (CAS: 66279-84-1). The final product ensures stability and bioavailability.
Contraindicated for patients with shellfish allergies. Store below 25°C in dry conditions. Medical supervision required for long-term use to monitor potential gastrointestinal interactions.